Physician profile
Manuel R Ramirez
NPI 1285613166
$2,255.65
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.49 · 2021: $176 · 2022: $279 · 2023: $1,380 · 2024: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,390 · Travel and Lodging: $311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,390.11 |
| Travel and Lodging | $311.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,268.19 | 2021-2024 | Intellis Adaptivestim, Mcgrath Mac, Bis |
| Pacira Pharmaceuticals Incorporated | $404.14 | 2019-2023 | Iovera |
| Edwards Lifesciences Corporation | $150.33 | 2024 | |
| Eagle Pharmaceuticals, INC. | $124.72 | 2023 | |
| Chiesi USA, INC. | $120.23 | 2023 | Cleviprex |
| Csl Behring | $105.74 | 2023 | Kcentra |
| Heron Therapeutics, INC. | $48.00 | 2019 | |
| Nalu Medical, INC. | $21.41 | 2021 | |
| Ibsa Pharma INC. | $12.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.